Evidence map›Paper›PMID 41140652›Full record

ArticleFrontiers in medicine2025

Knowledge, and attitude, and decisional conflict regarding biologics among patients with inflammatory bowel disease: a cross-sectional study.

Qianqian Li, Chenmei Xia, Chunxiao Chen, Yi Jiang, Lingxiao Jin, Jianmei Zhang, Linfeng Wu, Li Jiang, Xia Chen

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Qianqian LiDepartment of Gastroenterology, The First People's Hospital of Wenling (Taizhou University Affiliated Wenling Hospital), School of Medicine, Taizhou University, Taizhou, China.
Chenmei XiaDepartment of Gastroenterology, The First People's Hospital of Wenling (Taizhou University Affiliated Wenling Hospital), School of Medicine, Taizhou University, Taizhou, China.
Chunxiao ChenDepartment of Gastroenterology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Yi JiangDepartment of Gastroenterology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Lingxiao JinDepartment of Gastroenterology, The First People's Hospital of Wenling (Taizhou University Affiliated Wenling Hospital), School of Medicine, Taizhou University, Taizhou, China.
Jianmei ZhangDepartment of Gastroenterology, Lishui People's Hospital, Lishui, China.
Linfeng WuDepartment of Anesthesiology, Taizhou Central Hospital, Taizhou, China.
Li JiangDepartment of Gastroenterology, The First People's Hospital of Wenling (Taizhou University Affiliated Wenling Hospital), School of Medicine, Taizhou University, Taizhou, China.
Xia ChenDepartment of Gastroenterology, The First People's Hospital of Wenling (Taizhou University Affiliated Wenling Hospital), School of Medicine, Taizhou University, Taizhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: This study aimed to investigate the knowledge, attitude, and decisional conflict regarding biologic treatments among patients with inflammatory bowel disease (IBD) in China. Methods: This cross-sectional study included IBD patients recruited at the authors' hospital between July 2023 and January 2024. Data were collected using a self-administered questionnaire covering demographic characteristics, knowledge, attitude, and decisional conflict (measured by the Decisional Conflict Scale). Results: A total of 405 IBD patients participated, with 45.9% aged 30-49 years and 64% male. The average knowledge score was 6.03 ± 2.98 (possible range: 0-11), and the average attitude score was 24.36 ± 3.32 (possible range: 8-40). Among them, 60 (14.8%) patients exhibited significant decisional conflict. Spearman correlation analysis revealed a positive association between knowledge and attitude scores ( Conclusion: Older age, ulcerative colitis, lack of prior biologic use, and decisional conflict were associated with lower knowledge and lower attitude toward biologics among IBD patients. Targeted educational interventions may help reduce decisional conflict and improve patients' attitudes toward biologic therapy.

Indexed as

attitude to healthbiological therapydecision makinginflammatory bowel diseasesknowledge

Identifiers

PMID41140652
PMCPMC12546363

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.